Houston TX 贫血临床试验
5项针对 贫血的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
招募中1/2 期
- MD Anderson, Houston
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
招募中3 期
- The University of Texas-MD Anderson Cancer Center - Leukemia Center, Houston
- LUMI Research, Houston
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
招募中3 期
- MD Anderson Cancer Center, Houston
- The University of Utah-Huntsman Cancer Institute, Houston
- LUMI Research, Houston
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
招募中3 期
- U.T. MD Anderson Cancer Center, Division of Cancer Medicine, Houston
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
招募中
- The University of Texas Health Science Center at Houston, Houston
其他城市的 贫血试验
- New York City, NY7 项研究
- Atlanta, GA6 项研究
- Philadelphia, PA6 项研究
- Miami, FL6 项研究
- Tampa, FL5 项研究
- St. Louis, MO4 项研究
- Baldwin Park, CA4 项研究
- Winston-Salem, NC4 项研究
- Cleveland, OH4 项研究
- The Woodlands, TX3 项研究
- Gilbert, AZ3 项研究
- Nashville, TN3 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）123 项研究
- 转移性癌症104 项研究
- 结直肠癌101 项研究
- 卵巢癌89 项研究
- 急性髓系白血病86 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌62 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月29日。每项研究自行设定入选标准，由研究团队决定谁能参与。